These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7003391

  • 1. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
    Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML, Rowe JS, Havel RJ.
    N Engl J Med; 1981 Jan 29; 304(5):251-8. PubMed ID: 7003391
    [Abstract] [Full Text] [Related]

  • 2. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia.
    Illingworth DR, Phillipson BE, Rapp JH, Connor WE.
    Lancet; 1981 Feb 07; 1(8215):296-8. PubMed ID: 6109940
    [Abstract] [Full Text] [Related]

  • 3. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
    Vega GL, East C, Grundy SM.
    Arteriosclerosis; 1989 Feb 07; 9(1 Suppl):I135-44. PubMed ID: 2912427
    [Abstract] [Full Text] [Related]

  • 4. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
    Glueck CJ, Fallat RW, Mellies M, Tsang RC.
    Pediatrics; 1976 Jan 07; 57(1):68-74. PubMed ID: 174057
    [Abstract] [Full Text] [Related]

  • 5. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
    Malloy MJ, Kane JP, Kunitake ST, Tun P.
    Ann Intern Med; 1987 Nov 07; 107(5):616-23. PubMed ID: 3662275
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ, Linden CV, O'Connell MJ, Heilman J.
    Arch Intern Med; 1982 Apr 07; 142(4):721-3. PubMed ID: 7073415
    [Abstract] [Full Text] [Related]

  • 8. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL, Schonfeld G, Weidman SW.
    J Lab Clin Med; 1976 Dec 07; 88(6):1008-18. PubMed ID: 186544
    [Abstract] [Full Text] [Related]

  • 9. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA, Heimann KW.
    S Afr Med J; 1975 Jul 19; 49(31):1252-6. PubMed ID: 168650
    [Abstract] [Full Text] [Related]

  • 10. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H, Sakai T, Sakai Y, Yoshimura A, Watanabe A, Wakasugi T, Koizumi J, Takeda R.
    N Engl J Med; 1983 Mar 17; 308(11):609-13. PubMed ID: 6828091
    [Abstract] [Full Text] [Related]

  • 11. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
    Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT.
    N Engl J Med; 1990 Nov 08; 323(19):1289-98. PubMed ID: 2215615
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS, Noble RP, Dell RB.
    J Clin Invest; 1973 Oct 08; 52(10):2646-55. PubMed ID: 4729058
    [Abstract] [Full Text] [Related]

  • 14. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.
    Circulation; 1989 Jan 08; 79(1):16-28. PubMed ID: 2642754
    [Abstract] [Full Text] [Related]

  • 15. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR.
    Ann Intern Med; 1984 Nov 08; 101(5):598-604. PubMed ID: 6567462
    [Abstract] [Full Text] [Related]

  • 16. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB, Probstfield JL, Crow LO, Isaacson SO.
    Metabolism; 1981 Jun 08; 30(6):605-9. PubMed ID: 7231197
    [Abstract] [Full Text] [Related]

  • 17. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ, Stewart JM, Morgan HG, Lorimer AR, Shepherd J.
    Artery; 1980 Jun 08; 7(4):281-9. PubMed ID: 7213018
    [Abstract] [Full Text] [Related]

  • 18. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB, Bell C, Olson L.
    Metabolism; 1981 Jun 08; 30(6):610-5. PubMed ID: 7231198
    [Abstract] [Full Text] [Related]

  • 19. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA, Chernoff SB, Krehbiel P, Jackson B, DeCoursey S, Taylor H.
    Am J Cardiol; 1984 Jun 01; 53(11):1514-8. PubMed ID: 6375337
    [Abstract] [Full Text] [Related]

  • 20. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE, Illingworth DR.
    Proc Natl Acad Sci U S A; 1983 Dec 01; 80(24):7631-5. PubMed ID: 6584876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.